Tata
Memorial Centre launches ‘Thyroid Preceptorship’. This 6 day course will cover all aspects of thyroid
cancer management including clinical, surgical, imaging, pathology and basic
concepts of adjuvant radioiodine ablation and treatment.
Background:
Incidence of
thyroid cancer has increased in recent years. In the USA there is a 2.4 fold
rise and a growing trend is seen across Europe, South America & Asia. In
India as well, the incidence is on the rise. Thyroid cancers generally have
good prognosis with long term survivors and focus should be on reduction of
morbidity with its long term implications. Surgery is simple but requires
technical skill. There is however, a lack of uniformity in training amongst
thyroid surgeons from various backgrounds (General Surgery, ENT and Endocrine
Surgery). It is therefore imperative to have adequate training to prevent
longstanding complications.
Eligibility Criteria:
Candidate with surgical
background (M.S.) committed to management of thyroid cancers.
Course:
The course will be held bi annually with Five to Seven
candidates.
Venue:
Tata Memorial Hospital, Parel, Mumbai, India. 4000012.
Date:
16 January to 21 January 2017.
How to Apply:
Interested
candidates should email soft copy of their Curriculum Vitae (C.V.) to program
coordinator on following Email : mitrashilps@yahoo.co.in
Selection Process:
Applications
will be screened. Those fulfilling the eligibility criteria will be selected on
first cum first serve basis. It will be an ongoing process and waitlisted
candidates will be given chance in the next course. All correspondence with the
applicant will be done through email only.
Logistics:
Accommodation on request will be provided at TMH guest house on twin
sharing basis *
*subject to availability.
Program:
Radiology
Participants will be made
conversant in utility of ultrasound in diagnosis and management of thyroid
cancers. Following aspects will be covered
·
USG characterization of thyroid nodule using grey scale features based
on TIRADS & U1-U5 BTA classification.
·
Elastography
·
Guided Thyroid FNAC with onsite confirmation - criteria & technique
·
Post treatment ultrasound to visualize thyroid bed and neck
·
Role of various imaging methods for thyroid malignancies.
Pathology
·
Merits and demerits of the Bethesda system of reporting thyroid
cytology
·
Diagnostic challenges of differentiated thyroid cancer on FNAC &
frozen section
·
Variants of thyroid cancers
·
Pathology of Medullary thyroid cancer - sporadic and hereditary types.
·
Poorly differentiated thyroid carcinoma and anaplastic thyroid
carcinoma –Diagnostic pitfalls and
diagnostic implications
·
Molecular studies in thyroid cancer - their clinical and therapeutic
relevance
·
Synoptic reporting of thyroid carcinoma.
Nuclear Medicine
·
Introduction to various radionuclide molecules
·
Understanding the basis of I131therapy: pathophysiology and
its extrapolation in therapy
·
Risk stratification: When to use RAI in differentiated thyroid cancer?
·
Routine préparation & Strategies for ablation &
role of Recombinant TSH
·
Non-Iodine concentrating metastasis. When to investigate and how?
·
Persistent 131-Iodine uptake on scan. When is radionuclide treatment needed?
·
Neuroendocrine tumors & Medullary
thyroid cancer –FDG
PET and somatostatin receptor imaging
·
Role of FDG PET/CT in disease
management
·
Rising calcitonin in medullary carcinoma thyroid - Does it need to be
investigated?
·
Non-surgical treatment options in medullary carcinoma thyroid.
Surgery
Observe live thyroid surgeries
depending upon the availability of cases If no surgery is scheduled then video
demonstration would be done with a focus on:
·
Extent of surgery - does it vary
according to histological types?
·
Tips & Tricks during thyroid
surgery
·
Complications of thyroid surgery and
post operative management of thyroid cancers
·
Post thyroidectomy surveillance- TSH
suppression therapy & role of thyroglobulin.
·
ATA
Guidelines 2015 : an overview
Clinics
In the
clinics the candidates would be introduced to various issues related to
diagnosis, treatment modalities and follow up protocols in thyroid cancers.
Schedule:
There
will be a series of didactic lectures covering important aspects of thyroid cancer
management and visits to OPDs & OTs.
Faculty:
Pathology
Munita Bal,
Asawari Patil, Shubhda Kane.
Radiology
Supreeta
Arya, Abhishek Mahajan, Nilesh Sable
Nuclear Medicine
Sneha
Shah, Archi Agarwal, Nilendu Purandare, Venkatesh Rangarajan, Sandip Basu.
Surgical Oncology
Devendra
Chaukar, Prathmesh Pai, Pankaj Chaturvedi, Sudhir Nair, Deepa Nair, Gouri Pantvaidya,
Anuja Deshmukh, Shivakumar T, Anil D’Cruz.
Program Director:
Anil K D’Cruz, Director, Tata Memorial Hospital, Parel,
Mumbai, India
Tel- 022- 241774219
Email: docdcruz@gmail.com
Program Coordinator:
Shilpi
Sharma, MCh (Head Neck Surgical Oncology) Tata Memorial Hospital, Parel,
Mumbai, India.
M-
9594223801 Email: mitrashilps@yahoo.co.in
Supported by Unrestricted
Educational Grant from Genzyme
